Mirum Drug Patent Portfolio
Mirum owns 1 orange book drug protected by 9 US patents Given below is the list of Mirum's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12296050 | Pharmaceutical compositions comprising maralixibat and uses thereof | 05 Oct, 2043 | Active |
| US11229647 | Methods for treating cholestasis | 12 Feb, 2040 | Active |
| US11497745 | Methods for treating cholestasis | 12 Feb, 2040 | Active |
| US11918578 | Methods for treating cholestasis | 12 Feb, 2040 | Active |
| US10512657 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | 26 Oct, 2032 | Active |
| US11229661 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | 26 Oct, 2032 | Active |
| US11376251 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | 26 Oct, 2032 | Active |
| US12350267 | 26 Oct, 2032 | Active | |
| US11260053 | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | 26 May, 2031 | Active |
Latest Legal Activities on Mirum's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mirum.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Mar, 2024 | US11918578 |
|
Email Notification
Critical
| 05 Mar, 2024 | US11918578 |
| Recordation of Patent eGrant | 05 Mar, 2024 | US11918578 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Mar, 2024 | US11918578 |
| Mail Patent eGrant Notification | 05 Mar, 2024 | US11918578 |
| Patent eGrant Notification | 05 Mar, 2024 | US11918578 |
|
Email Notification
Critical
| 15 Feb, 2024 | US11918578 |
|
Issue Notification Mailed
Critical
| 14 Feb, 2024 | US11918578 |
| Dispatch to FDC | 03 Feb, 2024 | US11918578 |
|
Application Is Considered Ready for Issue
Critical
| 03 Feb, 2024 | US11918578 |
|
Email Notification
Critical
| 26 Jan, 2024 | US11918578 |
| Mailing Corrected Notice of Allowability | 26 Jan, 2024 | US11918578 |
| Corrected Notice of Allowability | 23 Jan, 2024 | US11918578 |
|
Pubs Case Remand to TC
Critical
| 23 Jan, 2024 | US11918578 |
|
Information Disclosure Statement considered
Critical
| 23 Jan, 2024 | US11918578 |
Mirum's Family Patents
Mirum drugs have patent protection in a total of 18 countries. It's US patent count contributes only to 31.2% of its total global patent coverage. Click
below to unlock the full patent family tree.
Mirum Drug List
Given below is the complete list of Mirum's drugs and the patents protecting them.
1. Livmarli
Livmarli is protected by 9 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12296050 | Pharmaceutical compositions comprising maralixibat and uses thereof |
05 Oct, 2043
(17 years from now)
| Active |
| US11229647 | Methods for treating cholestasis |
12 Feb, 2040
(14 years from now)
| Active |
| US11497745 | Methods for treating cholestasis |
12 Feb, 2040
(14 years from now)
| Active |
| US11918578 | Methods for treating cholestasis |
12 Feb, 2040
(14 years from now)
| Active |
| US10512657 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
26 Oct, 2032
(6 years from now)
| Active |
| US11229661 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
26 Oct, 2032
(6 years from now)
| Active |
| US11376251 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
26 Oct, 2032
(6 years from now)
| Active |
| US12350267 |
26 Oct, 2032
(6 years from now)
| Active | |
| US11260053 | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
26 May, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Livmarli's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List